Ruffolo Cesare, Toffolatti Luisa, Canal Fabio, Kotsafti Andromachi, Pagura Giulia, Pozza Anna, Campo Dell'Orto Marta, Ferrara Francesco, Massani Marco, Dei Tos Angelo P, Castoro Carlo, Bassi Nicolò, Scarpa Marco
1 Department of Surgery, Cà Foncello Regional Hospital, Treviso, Italy.
2 Pathology Unit, Cà Foncello Regional Hospital, Treviso, Italy.
Tumour Biol. 2017 Mar;39(3):1010428317692263. doi: 10.1177/1010428317692263.
Colorectal cancer incidence in patients undergoing screening protocols is decreasing because of the higher rate of discovered preneoplastic colonic lesions; however, adenomatous polyps may not always be removable endoscopically and surgery may still be necessary. The aim of this study was to assess the vascular endothelial growth factor expression in the different steps of colorectal carcinogenesis to explore its potential role as a marker of malignancy in polypoid lesions. A total of 92 subjects with colonic adenoma or cancer who underwent screening colonoscopy or surgery were prospectively enrolled. Real-time reverse transcription polymerase chain reaction for VEGF-A messenger RNA expression and immunohistochemistry for VEGF-A were performed. Immunoassays for VEGF-A, VEGF-C, VEGFR-1, VEGFR-2, and VEGFR-3 were also performed. Non-parametric statistics, receiver operating characteristic curve analysis, and logistic multiple regression analysis were used. VEGF-A messenger RNA expression was higher in patients with high-grade dysplasia or colorectal cancer than in those with low-grade dysplasia adenomas (p = 0.01). At immunohistochemistry, VEGF-A expression was significantly higher in colorectal cancer patients compared to dysplastic adenomas (p < 0.001), and the accuracy of VEGF-A expression for prediction of malignancy was 91.7 (95% confidence interval = 78.7-97.9). VEGF-C protein expression was lower in colorectal cancer patients than in simple adenomas (p = 0.02). VEGF-A levels were directly correlated to polyp size (rho = 0.73, p = 0.0062). Multivariate analysis demonstrated that malignancy and polyp size were independent predictors of VEGF-A mucosal levels. This study demonstrated that the VEGF-A expression changes along the colorectal carcinogenesis pathway showing a neat step up at the passage from high-grade dysplasia to invasive cancer. This feature might potentially be useful to stratify colorectal polyps in different risks of progression classes. Moreover, the high level of VEGF-A expression predicted the presence of lymphovascular invasion with good accuracy.
由于癌前结肠病变的检出率较高,接受筛查方案的患者中结直肠癌的发病率正在下降;然而,腺瘤性息肉不一定总能通过内镜切除,手术可能仍然是必要的。本研究的目的是评估血管内皮生长因子在结直肠癌发生不同阶段的表达,以探讨其作为息肉样病变恶性标志物的潜在作用。前瞻性纳入了92例接受筛查结肠镜检查或手术的结肠腺瘤或癌患者。进行了VEGF-A信使核糖核酸表达的实时逆转录聚合酶链反应和VEGF-A的免疫组织化学检测。还进行了VEGF-A、VEGF-C、VEGFR-1、VEGFR-2和VEGFR-3的免疫测定。使用了非参数统计、受试者工作特征曲线分析和逻辑多元回归分析。高级别异型增生或结直肠癌患者的VEGF-A信使核糖核酸表达高于低级别异型增生腺瘤患者(p = 0.01)。在免疫组织化学中,与发育异常腺瘤相比,结直肠癌患者的VEGF-A表达明显更高(p < 0.001),VEGF-A表达预测恶性肿瘤的准确性为91.7(95%置信区间 = 78.7 - 97.9)。结直肠癌患者的VEGF-C蛋白表达低于单纯腺瘤患者(p = 0.02)。VEGF-A水平与息肉大小直接相关(rho = 0.73,p = 0.0062)。多变量分析表明,恶性肿瘤和息肉大小是VEGF-A黏膜水平的独立预测因素。本研究表明,VEGF-A表达沿结直肠癌发生途径发生变化,在从高级别异型增生到浸润性癌的转变中出现明显升高。这一特征可能有助于将结直肠息肉分层为不同进展风险类别。此外,高水平的VEGF-A表达能较好地预测淋巴管侵犯的存在。